Covid-19 Vaccine Update: More 2.8 mil Doses have been administered around the World
|Vaccine Covid-19 and Global Covid-19 Updates. Photo: dangcongsan|
Covid-19 vaccine tracker: the global race to vaccinate
At least 208.317.348 doses of coronavirus vaccines have been administered around the world, data from 104 locations show.
After a year of breakneck research into more than 230 vaccine candidates, seven coronavirus vaccines are now in use in at least one country. Israel has been the fastest to roll out inoculations. More than a third of its population has already received at least one dose of vaccine.
The numbers shown here are updated frequently, using data compiled by the Our World in Data project at the University of Oxford as well as national data sources from some countries.
WHO authorize AstraZeneca COVID vaccine for emergency use
The World Health Organization (WHO) has announced that they are granting the AstraZeneca COVID-19 vaccine emergency approval. Millions of doses are now likely to be sent to the world’s most vulnerable people as part of COVAX, which is a global initiative aimed at equitable access to COVID-19 vaccines.
“Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk,” said Dr. Mariângela Simão, assistant director-general for Access to Medicines and Health Products at the WHO.
US Government Accountability Office report Johnson & Johnson have a short supply of their COVID-19 vaccine candidate
On January 29, 2021, the Johnson & Johnson corporation announced that they had completed phase 3 of the clinical trial of their experimental COVID-19 vaccine.
The vaccine — also known as the Janssen COVID-19 vaccine candidate — is a single-dose viral vector vaccine.
According to the Johnson & Johnson press release, their data indicate that the vaccine candidate is around 66% effective at preventing moderate to severe COVID-19.
Following these promising results, the corporation has submitted an application for Emergency Use Authorization (EUA) of the vaccine candidate to the Food and Drug Administration (FDA). They have also applied for European conditional marketing authorization to the European Medicines Agency.
Johnson & Johnson expect to receive a EUA from the FDA shortly, yet a current U.S. Government Accountability Office report has revealed that “[a]ccording to Janssen representatives, approximately 2 million doses will be delivered at the time of [EUA].”
This has prompted concerns about the vaccine candidate’s availability once U.S. authorities add it to the national vaccination rollout.
It also casts doubts on Johnson & Johnson’s promise that they will “supply 100 million doses to the U.S. in the first half of 2021.”
UK set to run world’s first coronavirus Human Challenge study
In the next few weeks, the United Kingdom will embark on the world’s first Human Challenge study. As a government press release explains, part of the research will “involve establishing the smallest amount of virus needed to cause infection.”
Israel data suggest that the Pfizer vaccine has led to over a 50% reduction in COVID-19 cases so far
Recent data from Israel, which has vaccinated around 3.5 million people, suggest that the Pfizer-BioNTech vaccine is indeed effective at preventing COVID-19.
At the time of the analysis, which was publicized on February 7, more than 75% of Israelis aged over 60 and around 25% of those aged 40–60 had received the first dose of the Pfizer-BioNTech vaccine.
Citing computational biologist Prof. Eran Segal, from the Weizmann Institute of Science, in Rehovot, Israel, Reuters further report that “Among the first fully vaccinated group, there was a 53% reduction in new cases [of COVID-19], a 39% decline in hospitalizations, and a 31% drop in severe illnesses from mid-January until February 6.”
South Africa replaces AstraZeneca with Johnson & Johnson shots
The results of a small study hinted that the AstraZeneca vaccine was less effective against the SARS-CoV-2 variant that scientists first identified in South Africa. In response, South Africa has scrapped the vaccine and is planning to roll out the Jonson & Johnson offering, which is not currently approved.
Next week, officials will distribute the vaccine to frontline healthcare workers. In a televised statement, Zweli Mkhize, South Africa’s Health Minister, told viewers that the vaccine was safe and had already undergone testing in 44,000 people.
He explained that “the Johnson & Johnson vaccine has been proven effective against the 501Y.V2 variant,” which is dominant in South Africa, “and the necessary approval processes for use in South Africa are underway.”
India’s vaccine rollout ramps up
India has registered the second-highest number of COVID-19 cases after the United States. On January 16, the country began one of the largest vaccination campaigns in the world. In less than 2 weeks, India has already vaccinated more than 2 million healthcare workers, according to Medicalnewstoday.
Northern Ireland COVID-19 Vaccination Programme
Coronavirus (COVID-19) vaccines have been approved for use in the UK and are available in Northern Ireland.
The Joint Committee on Vaccination and Immunisation (JCVI), an independent expert group, has recommended that the HSC offers vaccination first to those at the highest risk of catching the infection and of suffering serious complications if they catch the infection.
This includes frontline health and social care workers, care home residents and staff, and those with certain clinical conditions. When more vaccine becomes available, the vaccines will be offered to other people at risk as soon as possible.
The vaccines have met strict standards of safety, quality, and effectiveness set out by the Independent Medicines and Healthcare products Regulatory Agency (MHRA), Publichealth reported.
Brazil to start producing coronavirus vaccine in the first half of 2021
Brazil will begin to produce a Covid-19 vaccine in the first half of 2021, a state-run biological sciences institution has said.
With a technology transfer agreement with British pharmaceutical company AstraZeneca, Oswaldo Cruz Foundation based in Rio de Janeiro will be able to start making the vaccine in Brazil in April, said Marco Aurelio Krieger, the vice president of production and innovation in health with the foundation, in an interview with the UOL internet portal on Monday, Xinhua reported.
Brazil is set to receive more than 2 million doses of the AstraZeneca vaccine on Tuesday, according to Krieger.
The AstraZeneca vaccine and the CoronaVac vaccine developed by Chinese pharma company Sinovac are the two vaccines being applied in the country.
Global Covid-19 Status
Global Covid cases top 111.7 mn, death toll at 2.47 million.
The US is the worst-hit country with the world's highest number of cases and deaths at 28,188,296 and 500,236 respectively, according to the CSSE.
The total number of global coronavirus cases has topped 111.7 million, while the deaths have surged to more than 2.47 million, according to the Johns Hopkins University.
In its latest update on Tuesday morning, the University's Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and death toll stood at 111,705,909 and 2,473,742 respectively.
The US is the worst-hit country with the world's highest number of cases and deaths at 28,188,296 and 500,236 respectively, according to the CSSE.
India comes in second place in terms of cases at 11,005,850.
The other countries with more than a million confirmed coronavirus cases are Brazil (10,195,160), the UK (4,138,233), Russia (4,130,447), France (3,669,354), Spain (3,153,971), Italy (2,818,863), Turkey (2,646,526), Germany (2,399,499), Colombia (2,229,663), Argentina (2,069,751), Mexico (2,043,632), Poland (1,642,658), Iran (1,582,275), South Africa (1,504,588), Ukraine (1,354,545), Indonesia (1,288,833), Peru (1,283,309), Czech Republic (1,157,180) and the Netherlands (1,075,425), the CSSE figures showed.
Brazil currently accounts for the second-highest number of Covid-19 fatalities at 247,143, followed by Mexico 180,536 in third place and India 156,385 in fourth.
Meanwhile, the nations with a death toll above 20,000 are the UK (120,988), Italy (95,992), France (84,764), Russia (82,255), Germany (68,079), Spain (67,636), Iran (59,572), Colombia (58,974), Argentina (51,359), South Africa (49,150), Peru (45,097), Poland (42,188), Indonesia (34,691), Turkey (28,138), Ukraine (26,531), Belgium (21,923) and Canada (21,720).
UK records another 10,641 coronavirus cases, 178 deaths in 24 hrs
Another 10,641 people in Britain have tested positive for Covid-19, bringing the total number of coronavirus cases in the country to 4,126,150, according to official figures released on Monday.
The country also reported another 178 coronavirus-related deaths. The total number of coronavirus-related deaths in Britain now stands at 120,757.
These figures only include the deaths of people who died within 28 days of their first positive test, Xinhua news agency reported.
The latest figures were revealed as more than 17.7 million people in Britain have been given the first jab of the coronavirus vaccine.
Also on Monday, British Prime Minister Boris Johnson announced his long-anticipated "roadmap" exiting the lockdown.
Schools in England will reopen from March 8 as the first part of a four-step plan, which Johnson said was designed to be "cautious but irreversible"
In the second step, non-essential retail, hairdressers, and public buildings like libraries and museums will reopen from April 12, Johnson told lawmakers at the House of Commons, the lower house of the British parliament.
In the third step, from May 17, the "rule of six" will be abolished for outdoor gatherings if the data allows and the gathering of up to 30 people will be permitted.
In the fourth step, from June 21, all legal social restrictions are expected to be removed, with the reopening of the final closed sectors of the economy including nightclubs, said Johnson.
England is currently under the third national lockdown since the outbreak of the pandemic in the country. Similar restriction measures are also in place in Scotland, Wales, and Northern Ireland, Business Standard reported.
US tops 500,000 coronavirus deaths, matching the toll of three wars
The COVID-19 death toll in the US has topped 500,000, all but matching the number of Americans killed in World War II, Korea and Vietnam combined.
The lives lost, as recorded by Johns Hopkins University on Monday, are about equal to the population of Kansas City, Missouri, and greater than that of Miami; Raleigh, North Carolina; or Omaha, Nebraska.
And despite the rollout of vaccines since mid-December, a closely watched model from the University of Washington projects more than 589,000 dead by June 1.
The US toll is by far the highest reported in the world, and the true numbers are thought to be significantly greater, in part because of the many cases that were overlooked, especially early in the outbreak.
Average daily deaths and cases have plummeted in the past few weeks, but experts warn that dangerous variants could cause the trend to reverse itself.
Some experts say not enough Americans have been inoculated yet for the vaccine to be making much of a difference.
Instead, the drop-off in deaths and cases has been attributed to the passing of the holidays; the cold and bleak days of midwinter, when many people are inclined to stay home; and better adherence to mask rules and social distancing.
As of 18 February 2021, at least seven different vaccines across three platforms have been rolled out in countries. Vulnerable populations in all countries are the highest priority for vaccination.
At the same time, more than 200 additional vaccine candidates are in development, of which more than 60 are in clinical development. COVAX is part of the ACT Accelerator, which WHO launched with partners in 2020. COVAX, the vaccines pillar of ACT Accelerator, convened by CEPI, Gavi and WHO, aims to end the acute phase of the COVID-19 pandemic by:
- speeding up the development of safe and effective vaccines against COVID-19;
- supporting the building of manufacturing capabilities; and
- working with governments and manufacturers to ensure fair and equitable allocation of the vaccines for all countries – the only global initiative to do so.
Vaccines are a critical new tool in the battle against COVID-19 and it is hugely encouraging to see so many vaccines proving successful and going into development. Working as quickly as they can, scientists from across the world are collaborating and innovating to bring us tests, treatments, and vaccines that will collectively save lives and end this pandemic, according to WHO.
Who can get the COVID-19 vaccine
The NHS is currently offering the COVID-19 vaccine to people most at risk from coronavirus.
In England, the vaccine is being offered in some hospitals and pharmacies, at local vaccination centres run by GPs and at larger vaccination centres. More centres are opening all the time.
It's being given to:
- people aged 64 and over
- people who are at high risk from coronavirus (clinically extremely vulnerable)
- people who are at moderate risk from coronavirus (clinically vulnerable)
- people who live or work in care homes
- health and social care workers
- people who are eligible for Carer's Allowance – find out more about Carer's Allowance on GOV.UK
The order in which people will be offered the vaccine is based on advice from the Joint Committee on Vaccination and Immunisation (JCVI).
Advice if you're of childbearing age, pregnant or breastfeeding
There's no evidence the COVID-19 vaccine is unsafe if you're pregnant. But more evidence is needed before you can routinely be offered it.
The JCVI has updated its advice to recommend you may be able to have the vaccine if you're pregnant and:
- at high risk of getting coronavirus because of where you work
- have a health condition that means you're at high risk of serious complications of coronavirus
You can have the COVID-19 vaccine if you're breastfeeding.
Speak to a healthcare professional before you have the vaccination. They will discuss the benefits and risks with you.
You do not need to avoid pregnancy after vaccination. The vaccine cannot give you or your baby COVID-19.
How safe is the COVID-19 vaccine?
The vaccines approved for use in the UK have met strict standards of safety, quality and effectiveness set out by the Independent Medicines and Healthcare products Regulatory Agency (MHRA).
Any coronavirus vaccine that is approved must go through all the clinical trials and safety checks all other licensed medicines go through. The MHRA follows international standards of safety.
Other vaccines are being developed. They will only be available on the NHS once they have been thoroughly tested to make sure they are safe and effective.
So far, millions of people have been given a COVID-19 vaccine and reports of serious side effects, such as allergic reactions, have been very rare. No long-term complications have been reported, NHS cited.
| Covid-19 Update: Latest News of Vaccines, Virus and Situations around the World |
Covid-19 Latest News: U.S. vaccine rollout vastly, but Americans may still be wearing face masks in 2022; Rollout begins throughout Australia; In Canada, vaccine delivery ...
| Latest updatations about Covid-19 vaccine: 202 million doses all around the world |
The covid-19 situation is still ongoing all around the world and this has prompted us to quickly find a solution. Check the information given by ...
| NASA's Perseverance Rover delivered First Helicopter, '10.9 million Names' and 'Covid-19 Tribute' to Mars |
NASA's Perseverance rover delivered weird things such as first helicopter, '10.9 million Names', 'Mastcam-Z: "Are we alone?" and 'Covid-19 Tribute' to Mars.